首页 正文

Antibody-drug conjugate therapies in multiple myeloma-what's next on the horizon?

{{output}}
Targeted immunotherapy has arisen over the past decade to the forefront of cancer care. Notably, targeted therapies such as antibody-drug conjugates (ADCs) are becoming more recognized for a novel approach in cancer treatment. The mechanism of action of ADCs i... ...